Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial Misinterpretation.
Lin TA, McCaw ZR, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Sherry AD, Noticewala SS, Fuller CD, Thomas CR Jr, Sun R, Lee JJ, Lin R, Yuan Y, Shyr Y, Meirson T, Ludmir EB. Lin TA, et al. Among authors: patel r. Clin Cancer Res. 2024 Oct 15;30(20):4791-4799. doi: 10.1158/1078-0432.CCR-24-0566. Clin Cancer Res. 2024. PMID: 39133081
Exclusion of patients with brain metastases from cancer clinical trials.
Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Patel RR, et al. Neuro Oncol. 2020 Apr 15;22(4):577-579. doi: 10.1093/neuonc/noz246. Neuro Oncol. 2020. PMID: 31900480 Free PMC article. No abstract available.
Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.
Patel R, Ludmir EB, Miccio JA, Menon H, Barsky AR, Mesko SM, Kodali M, Lautenschlaeger T, Adeberg S, Simone CB 2nd, Verma V. Patel R, et al. Pract Radiat Oncol. 2020 Nov-Dec;10(6):423-433. doi: 10.1016/j.prro.2020.02.007. Epub 2020 Feb 20. Pract Radiat Oncol. 2020. PMID: 32088429 Review.
Food and Drug Administration approvals in phase 3 Cancer clinical trials.
Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Abi Jaoude J, et al. Among authors: patel r. BMC Cancer. 2021 Jun 12;21(1):695. doi: 10.1186/s12885-021-08457-5. BMC Cancer. 2021. PMID: 34118915 Free PMC article. Clinical Trial.
Impact factor and citation metrics in phase III cancer trials.
Abi Jaoude J, Kouzy R, Rooney M, Thompson P, Patel R, Turner MC, Ghabach M, Fuller CD, Minsky BD, Taniguchi CM, Ludmir EB. Abi Jaoude J, et al. Among authors: patel r. Oncotarget. 2021 Aug 31;12(18):1780-1786. doi: 10.18632/oncotarget.28044. eCollection 2021 Aug 31. Oncotarget. 2021. PMID: 34504650 Free PMC article.
The radiotherapy quality assurance gap among phase III cancer clinical trials.
Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, Fuller CD, Ludmir EB. Corrigan KL, et al. Among authors: patel rr. Radiother Oncol. 2022 Jan;166:51-57. doi: 10.1016/j.radonc.2021.11.018. Epub 2021 Nov 25. Radiother Oncol. 2022. PMID: 34838891 Free PMC article. Clinical Trial.
10,175 results
You have reached the last available page of results. Please see the User Guide for more information.